Healthcare provider profile · identity verified

Kati Sisson

Nurse Practitioner · BATAVIA, NY · NPI 1508226622

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	522	173
Omeprazole	Omeprazole	306	103
Lisinopril	Lisinopril	294	95
Levothyroxine Sodium	Levothyroxine Sodium	275	83
Amlodipine Besylate	Amlodipine Besylate	249	90
Rosuvastatin Calcium	Rosuvastatin Calcium	224	88
Hydrochlorothiazide	Hydrochlorothiazide	178	51
Losartan Potassium	Losartan Potassium	156	54
Gabapentin	Gabapentin	149	50
Sertraline Hcl	Sertraline Hcl	145	46
Metformin Hcl Er	Metformin Hcl	137	41
Glipizide Er	Glipizide	129	31
Metformin Hcl	Metformin Hcl	127	43
Pantoprazole Sodium	Pantoprazole Sodium	127	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	123	43
Metoprolol Succinate	Metoprolol Succinate	115	43
Ozempic	Semaglutide	112	19
Albuterol Sulfate Hfa	Albuterol Sulfate	105	55
Pravastatin Sodium	Pravastatin Sodium	101	32
Meloxicam	Meloxicam	99	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	21
Trazodone Hcl	Trazodone Hcl	95	29
Duloxetine Hcl	Duloxetine Hcl	93	22
Eliquis	Apixaban	91	24
Prednisone	Prednisone	88	76
Famotidine	Famotidine	84	20
Tamsulosin Hcl	Tamsulosin Hcl	83	27
Allopurinol	Allopurinol	82	29
Metoprolol Tartrate	Metoprolol Tartrate	77	25
Furosemide	Furosemide	76	22
Montelukast Sodium	Montelukast Sodium	74	17
Fluoxetine Hcl	Fluoxetine Hcl	69	22
Pioglitazone Hcl	Pioglitazone Hcl	66	19
Simvastatin	Simvastatin	61	19
Fluticasone Propionate	Fluticasone Propionate	58	25
Bupropion Xl	Bupropion Hcl	56	15
Atenolol	Atenolol	55	17
Ezetimibe	Ezetimibe	55	17
Jardiance	Empagliflozin	54	14
Potassium Chloride	Potassium Chloride	54	15
Torsemide	Torsemide	53	14
Pregabalin	Pregabalin	51	11
Januvia	Sitagliptin Phosphate	48	suppressed
Buspirone Hcl	Buspirone Hcl	45	13
Glipizide	Glipizide	40	11
Alendronate Sodium	Alendronate Sodium	39	13
Mirtazapine	Mirtazapine	39	11
Alprazolam	Alprazolam	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	11
Paroxetine Hcl	Paroxetine Hcl	38	12
Chlorthalidone	Chlorthalidone	37	14
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Carvedilol	Carvedilol	36	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Irbesartan	Irbesartan	34	14
Glimepiride	Glimepiride	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	28
Nystatin	Nystatin	29	17
Hydroxyzine Hcl	Hydroxyzine Hcl	28	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	12
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Lorazepam	Lorazepam	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	21
Xarelto	Rivaroxaban	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Azithromycin	Azithromycin	24	21
Tramadol Hcl	Tramadol Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Baclofen	Baclofen	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	11
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Amoxicillin	Amoxicillin	15	15
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Finasteride	Finasteride	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	14
Clonidine Hcl	Clonidine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Ramipril	Ramipril	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error